Recent matter

Rutgers & Posch advised the shareholders of De Jong & Laan in relation to the participation of Waterland Private Equity Investments in De Jong & Laan. This participation is the first time in the Netherlands that a private equity firm invests in the Dutch accountancy market. The team of Rutgers & Posch consisted of Lennaert Posch, Justus Fortuyn, Tijmen Noordoven, Rik Analbers and Qury van Vliet. For more…

Rutgers & Posch advised Dutch fintech in3 on its structured finance transaction with Waterfall Asset Management LLC. in3 provides short-term financing in the form of Buy Now, Pay Later. For more detail, please see in3’s press statement of 18 May 2022. The R&P team consisted of Maarten Ahsmann (Finance), Bas Visée (Corporate) and Kees Westermann (Finance).

Rutgers & Posch advised Accsys Technologies, a chemical technology company, on its accelerated bookbuild offering to institutional investors of €20 million. Numis Securities, Investec Bank and ABN AMRO Bank, acted as joint bookrunners. The admission to listing and trading of the new shares on Euronext Amsterdam and to trading on the Alternative Investment Market in London took place on 30 May 2022. The proceeds of the offering will…

Rutgers & Posch advised the shareholders of Medical Production Technology Europe in relation to the sale of the company to Medical Manufacturing Technologies. The team of Rutgers & Posch consisted of Lennaert Posch and Justus Fortuyn.

Prometheus Group, a leading global provider of asset management operations and optimizations Rutgers & Posch advised Prometheus Group in relation to the acquisition of LUCY Industrial Management Solutions (IMS). The team of Rutgers & Posch consisted of Matthijs van den Broek en Justus Fortuyn.

Rutgers & Posch advises Zorg van de Zaak, a leading occupational health network for working people in the Netherlands, on the aquisition by Parcom Capital, a leading Benelux private equity fund. The network of Zorg van de Zaak reaches more than 1,3 million employees through 67.000 employers. The acquisition is still subject to certain regulatory approvals and compliance with co-determination procedures. The team of Rutgers & Posch consists…